Boehringer Ingelheim Pharma GmbH & Co. KG (manufacturing, primary and secondary packaging, quality control (including microbiological purity) at batch release and during shelf life, batch release)
UkraineAll drugs from this manufacturer
-
The drug is used for the short-term treatment of osteoarthritis exacerbations, as well as for the long-term symptomatic treatment of rheumatoid arthritis and ankylosing spondylitis in adults and children aged 16 years and older.
Dosage form: tablets
Active substance Dosage meloxicam 7.5 mg ATC: M01AC06
-
The drug is used for the short-term treatment of osteoarthritis exacerbations, as well as for the long-term symptomatic treatment of rheumatoid arthritis and ankylosing spondylitis in adults and children aged 16 years and older.
Dosage form: tablets
Active substance Dosage meloxicam 15 mg ATC: M01AC06